Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Real Travel Adventures September 2008 Gary Niemann	Oral Allergy Immunotherapy In Denver Oral allergy immunotherapy utilizing a potency-enhancing liquid vehicle is painless, convenient, effective, safe, and economical, and can offer relief for millions of allergy sufferers
The Motley Fool August 31, 2007 Brian Orelli	Guidelines to Stop the Wheezing Investors, new asthma guidelines will affect some drug makers. The FDA isn't the only organization that affects how well drugs do in the marketplace.
AskMen.com June 22, 2003 Mike Davison	Asthma: Are You At Risk? The recurrent and debilitating effects of asthma sometimes appear suddenly, so it is best to arm yourself with knowledge about this serious and chronic condition.
Nurse Practitioner April 2010 Benninger & McCallister	Asthma in pregnancy: Reading between the lines Asthma is one of the most common, chronic medical conditions that can complicate pregnancy, affecting between 4% and 8% of this population.
American Family Physician August 1, 2004	Allergy Shots-What You Need to Know An informational consumer pamphlet on this type of allergy therapy.
American Journal of Nursing May 2010 Corbridge & Corbridge	Asthma in Adolescents and Adults This article outlines current guideline recommendations for asthma and reviews what clinicians need to teach patients about its pathophysiology, pharmacotherapy, self monitoring, and environmental control.
The Motley Fool June 25, 2010 Brian Orelli	Merck Breathes Life Into an Acquired Pipeline The acquisition is paying off with newly approved drugs.
Real Travel Adventures February 2008 Bonnie Neely	Simple Oral Therapy In Denver Prevents Allergic Symptoms For Life! The Allergy Clinic makes patients comfortable again by eliminating their allergic symptoms through simple daily oral drops.
Seasoned Cooking May 2005 Michael Fick	How's Your Breathing This Allergy Season? An occasional sneeze means nothing, so just let'er blow. But frequent sneezes usually mean something -- and this time of year it's probably allergies. Here's what you can do to help stifle the sneeze.
Nurse Practitioner December 2010 Kathy J. Morris	Management of Exercise-Induced Bronchospasm in Adolescents with Asthma Collaboration between the nurse practitioner and adolescent is essential to develop an asthma management plan that will provide for optimal physical activity and prevent asthma exacerbations while exercising.
Pharmaceutical Executive December 1, 2008 Ron Feemster	The 2008 Pipeline Report We scrub industry's pipeline to find the drugs that everyone will be talking about in 2009 and beyond.
Nurse Practitioner September 2008 Elizabeth Neville Regan	Diagnosing Rhinitis: Viral and Allergic Characteristics Rhinitis is a group of disorders characterized by inflammation and irritation of mucous membranes of the nose. These disorders may be infectious, allergic, or inflammatory in origin.
Managed Care March 2004 Christine A. Sorkness	IgE-Blocking Therapy for Difficult-to-Treat Asthma: A Brief Review Omalizumab, a novel therapy that targets specific steps in the inflammatory cascade of asthma, may benefit the hard-to-treat patient.
American Family Physician May 1, 2006 Quillen & Feller	Diagnosing Rhinitis: Allergic vs. Nonallergic Allergic rhinitis, the most common type of rhinitis, generally can be differentiated from the numerous types of nonallergic rhinitis through a thorough history and physical examination.
Chemistry World September 25, 2013 Phillip Broadwith	New respiratory drugs neck and neck A flurry of regulatory approvals has seen three new drugs approved for asthma and chronic obstructive pulmonary disease in the European and Japanese markets.
Pharmaceutical Executive December 1, 2010 Walter Armstrong	The Next Wave: Pharm Exec's 2011 Pipeline Report 42 of the best new drugs in development or parked at the FDA
The Motley Fool December 5, 2005 W.D. Crotty	Rigel Pharmaceuticals Gets Stomped The biotech tumbles on poor phase 2 trial results for an allergy drug. Until another compound begins to offer glimmers of hope, this stock will probably offer little if any price appreciation.
The Motley Fool November 8, 2010 Brian Orelli	No Sticking Point Here: Pfizer's Potential Blockbuster Works Translating successful phase 2 results into a positive phase 3 trial can require a bit of luck, especially for a disease such as rheumatoid arthritis where the outcomes are somewhat subjective.
American Family Physician August 15, 2002 James T. Li	Allergy Testing Allergic diseases are among the most common medical problems encountered in ambulatory practice. Allergy testing can help the physician determine if a patient's problem is caused by an allergy and identify the specific problem allergens.
Pharmaceutical Executive December 1, 2005 Ron Feemster	The PharmExec 2005 Pipeline Report Dry? Not quite. Instead of 1990s-style blockbusters, pharma's new molecules are niche drugs, cancer treatments and -- at last -- innovative mechanisms for troublesome targets: Acomplia [rimonabant] by Sanofi-Aventis... AMG 162 [denosumab] by Amgen... etc.
American Family Physician January 1, 2007 Scow et al.	Leukotriene Inhibitors in the Treatment of Allergy and Asthma Approximately one third of all prescriptions for maintenance therapy in patients with persistent asthma are for leukotriene inhibitors; however, evidence of their effectiveness compared with other treatments is mixed.
American Family Physician April 1, 2001 James P. Kemp & Judith A. Kemp	Management of Asthma in Children The prevalence of asthma in children has increased 160 percent since 1980, and the disease currently affects nearly 5 million children in the United States...
AskMen.com October 25, 2001 Sebastien Stefanov	Do You Have Food Allergies? It seems everybody nowadays has their own personal kryptonite, but allergies are no laughing matter. Some reactions can be deadly, and even if allergic reactions are not severe, they can still be annoying...
The Motley Fool July 25, 2011 Brian Orelli	Bristol-Myers' Acquisition Could Pay for Itself It will gain access to potential milestones.
Chemistry World September 2010	Column: In the pipeline Derek Lowe considers the quandaries of living in the age of the kinase
The Motley Fool August 28, 2007 Brian Orelli	A Combination to Clear Your Head Merck and Schering-Plough get together again. But who can blame them? Their partnerships have been making both companies lots of money. Investors, take note.
American Family Physician May 15, 2005 Courtney et al.	Childhood Asthma: Treatment Update The prevalence of childhood asthma has risen significantly over the past four decades. This article summarizes the treatment of asthma in children, with an emphasis on new modalities and the results of recent studies.
Chemistry World August 29, 2014 Sarah Houlton	Roche to buy InterMune for respiratory boost Roche is to acquire InterMune in a deal worth $8.3 billion.
AskMen.com Jacob Franek	Allergy Armor For 2009 Here are a few of 2009's new allergy armor products.
Chemistry World March 17, 2014 Eleanor Merritt	Four steps to asthma treatment Scientists based in the US have devised a new way to make Montelukast, a drug used in the treatment of asthma and seasonal allergies.
BusinessWeek November 21, 2005 Catherine Arnst	How To Manage Your Asthma Asthma sufferers can achieve near-perfect freedom from shortness of breath.
Pharmaceutical Executive November 1, 2012	Pharm Exec's 2013 Pipeline Report In this year's report, Ben Comer reveals that drug approvals are up, as new discoveries in biology peel away symptomology to expose underlying causes.
The Motley Fool September 28, 2010 Brian Orelli	Don't Get Stuck! Invest in Needle-Free Drugs Here's how to make some money off society's general disdain for needles through next-generation drugs.
The Family Room	Treating Kids' Allergies Adults with allergies sometimes tough it out, if they know their allergy season is limited or if they feel they can handle the sniffles and runny eyes. But you can't take that same attitude with a child....
Managed Care May 2007 Jill Karpel et al.	The Appropriate Omalizumab Patient Management of the uncontrolled asthma patient and case examples.
The Motley Fool May 21, 2010 Brian Orelli	And You Thought Biotech Was High-Risk, High-Reward Large clinical trials make cardiovascular drugs risky, but the rewards are there, too.
American Family Physician January 15, 2005 Liya Davydov	STEPS - New Drug Reviews Omalizumab is an immunomodulatory therapy for the control of symptoms in patients with moderate to severe allergic asthma uncontrolled with conventional therapy.
The Motley Fool June 3, 2011 Frank Vinluan	GSK Sees Positive Results on Asthma, COPD Drug Expected to Succeed Advair GSK gets good news.
The Motley Fool June 26, 2009 Brian Orelli	The $16 Billion Market That Could Make You Rich A large market just waiting to be taken over.
American Family Physician August 15, 2004 Huggins & Looney	Allergen Immunotherapy The major objectives of the practice are to reduce responses to allergic triggers that precipitate symptoms in the short term and to decrease inflammatory response and prevent development of persistent disease in the long term.
The Motley Fool March 14, 2008 Brian Orelli	Weighing In on Obesity Drugs Could investing in drugmakers that produce weight-loss drugs help fatten your wallet?
The Motley Fool September 7, 2006 Brian Lawler	SkyePharma Makes a Deal The pharmaceutical sells European rights to a promising asthma drug. With approval not guaranteed, and a cutthroat market for asthma drugs, this deal looks pretty good for Skye overall.
Bio-IT World October 9, 2002 Malorye Branca	The Path to Personalized Medicine The tactics have changed, sometimes dramatically, but hints of the promise of pharmacogenomics are finally starting to trickle in from studies of asthma, cancer, and drug response.
American Family Physician March 1, 2003 James C. Higgins	The 'Crashing Asthmatic' Asthma is one of the most common chronic disorders managed by family physicians. A "crashing asthmatic" is a patient with asthma who is clinically deteriorating into respiratory failure or arrest despite initial treatment. Managing such a patient can be a major challenge.
Nursing November 2011 Lawson & Pruitt	Issues in Obesity, Part 2: Obesity Weighs Heavily on Lung Function A look at the impact of obesity on asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea.
Real Travel Adventures January 2008 Bonnie Neely	Travel To Cure Your Allergy Miseries Make a trip to Denver, CO that saves your health and enables outdoor fun, even in allergy seasons.
American Family Physician December 1, 2001 Sami Youakim	Work-Related Asthma Work-related asthma is induced or incited by substances or conditions specific to the workplace. It has become the most common occupational respiratory disease in many countries...
American Family Physician September 1, 2004 Matthew Mintz	Asthma Update: Part I. Diagnosis, Monitoring, and Prevention of Disease Progression The National Asthma Education and Prevention Program Expert Panel has updated its clinical guidelines on asthma medications, prevention of disease progression, and patient self-management.
American Family Physician April 1, 2001	Take Control of Your Asthma What is asthma?... How can I control my asthma?...
American Family Physician August 1, 2002 German & Harper	Environmental Control of Allergic Diseases National and international guidelines for the management of asthma and allergic rhinitis include recommendations for environmental control of allergens and irritants.